RAP
Click for more information
0.00% 20.5¢ raptor resources limited

Ann: Medgate extends European ResAppDx trial, page-3

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. FredP
    620 Posts.
    lightbulb Created with Sketch. 93
    clock Created with Sketch.
    03/06/21
    08:51
    Post #: 53610034
    Extending a trial - there's a surprise.


    Hope it says something about revenue - or them paying for it
    RAP Price at posting: 5.4¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.